Insufficient scRNA-seq data for expression of GTSE1 at single-cell level.
Insufficient scRNA-seq data for expression of GTSE1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 93% | 748.64 | 1675 / 1809 | 98% | 24.70 | 463 / 472 |
lung | 73% | 115.90 | 421 / 578 | 88% | 14.31 | 1017 / 1155 |
stomach | 61% | 167.15 | 219 / 359 | 99% | 17.90 | 282 / 286 |
intestine | 58% | 199.28 | 564 / 966 | 98% | 17.31 | 514 / 527 |
esophagus | 48% | 211.85 | 698 / 1445 | 99% | 20.85 | 182 / 183 |
breast | 50% | 45.50 | 228 / 459 | 88% | 11.60 | 985 / 1118 |
uterus | 28% | 22.94 | 47 / 170 | 98% | 23.82 | 449 / 459 |
ovary | 31% | 32.03 | 56 / 180 | 93% | 12.24 | 399 / 430 |
bladder | 29% | 28.95 | 6 / 21 | 95% | 16.38 | 479 / 504 |
adrenal gland | 81% | 97.15 | 210 / 258 | 25% | 2.27 | 57 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.12 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.48 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.70 | 1 / 1 |
spleen | 99% | 407.36 | 238 / 241 | 0% | 0 | 0 / 0 |
pancreas | 14% | 11.04 | 46 / 328 | 80% | 6.63 | 142 / 178 |
peripheral blood | 73% | 805.67 | 680 / 929 | 0% | 0 | 0 / 0 |
liver | 27% | 34.41 | 60 / 226 | 46% | 4.06 | 188 / 406 |
brain | 12% | 6.94 | 305 / 2642 | 55% | 7.21 | 386 / 705 |
prostate | 40% | 32.70 | 97 / 245 | 24% | 1.45 | 120 / 502 |
kidney | 34% | 49.29 | 30 / 89 | 23% | 1.54 | 205 / 901 |
eye | 0% | 0 | 0 / 0 | 55% | 3.16 | 44 / 80 |
adipose | 54% | 60.36 | 650 / 1204 | 0% | 0 | 0 / 0 |
thymus | 30% | 25.00 | 193 / 653 | 18% | 4.88 | 108 / 605 |
heart | 36% | 29.49 | 310 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 27% | 22.53 | 358 / 1335 | 0% | 0 | 0 / 0 |
muscle | 3% | 1.52 | 22 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007017 | Biological process | microtubule-based process |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005881 | Cellular component | cytoplasmic microtubule |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
GO_0008017 | Molecular function | microtubule binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | GTSE1 |
Protein name | G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog) |
Synonyms | |
Description | FUNCTION: May be involved in p53-induced cell cycle arrest in G2/M phase by interfering with microtubule rearrangements that are required to enter mitosis. Overexpression delays G2/M phase progression. |
Accessions | Q9NYZ3 ENST00000454366.2 |